188 related articles for article (PubMed ID: 18294091)
1. Steady-state pharmacokinetic, safety, and tolerability profiles of quetiapine, norquetiapine, and other quetiapine metabolites in pediatric and adult patients with psychotic disorders.
Winter HR; Earley WR; Hamer-Maansson JE; Davis PC; Smith MA
J Child Adolesc Psychopharmacol; 2008 Feb; 18(1):81-98. PubMed ID: 18294091
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic profiles of extended release quetiapine fumarate compared with quetiapine immediate release.
Figueroa C; Brecher M; Hamer-Maansson JE; Winter H
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):199-204. PubMed ID: 18948162
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics, tolerability, and clinical effectiveness of quetiapine fumarate: an open-label trial in adolescents with psychotic disorders.
McConville BJ; Arvanitis LA; Thyrum PT; Yeh C; Wilkinson LA; Chaney RO; Foster KD; Sorter MT; Friedman LM; Brown KL; Heubi JE
J Clin Psychiatry; 2000 Apr; 61(4):252-60. PubMed ID: 10830145
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and tolerability of extended-release quetiapine fumarate in Han Chinese patients with schizophrenia.
Li Q; Su YA; Liu Y; Chen JX; Tan YL; Yang FD; Si TM
Clin Pharmacokinet; 2014 May; 53(5):455-65. PubMed ID: 24385309
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of quetiapine in elderly patients with selected psychotic disorders.
Jaskiw GE; Thyrum PT; Fuller MA; Arvanitis LA; Yeh C
Clin Pharmacokinet; 2004; 43(14):1025-35. PubMed ID: 15530131
[TBL] [Abstract][Full Text] [Related]
6. Effect of fluoxetine and imipramine on the pharmacokinetics and tolerability of the antipsychotic quetiapine.
Potkin SG; Thyrum PT; Alva G; Carreon D; Yeh C; Kalali A; Arvanitis LA;
J Clin Psychopharmacol; 2002 Apr; 22(2):174-82. PubMed ID: 11910263
[TBL] [Abstract][Full Text] [Related]
7. Self-reported sedation profile of immediate-release quetiapine fumarate compared with extended-release quetiapine fumarate during dose initiation: a randomized, double-blind, crossover study in healthy adult subjects.
Datto C; Berggren L; Patel JB; Eriksson H
Clin Ther; 2009 Mar; 31(3):492-502. PubMed ID: 19393840
[TBL] [Abstract][Full Text] [Related]
8. Single-dose relative bioavailability of a new quetiapine fumarate extended-release formulation: a postprandial, randomized, open-label, two-period crossover study in healthy Uruguayan volunteers.
Estevez-Carrizo FE; Parrillo S; Ercoli MC; Estevez-Parrillo FT
Clin Ther; 2011 Jun; 33(6):738-45. PubMed ID: 21704238
[TBL] [Abstract][Full Text] [Related]
9. Open-label steady-state pharmacokinetic drug interaction study on co-administered quetiapine fumarate and divalproex sodium in patients with schizophrenia, schizoaffective disorder, or bipolar disorder.
Winter HR; DeVane CL; Figueroa C; Ennis DJ; Hamer-Maansson JE; Davis PC; Smith MA
Hum Psychopharmacol; 2007 Oct; 22(7):469-76. PubMed ID: 17729385
[TBL] [Abstract][Full Text] [Related]
10. The safety and pharmacokinetics of quetiapine when coadministered with haloperidol, risperidone, or thioridazine.
Potkin SG; Thyrum PT; Alva G; Bera R; Yeh C; Arvanitis LA
J Clin Psychopharmacol; 2002 Apr; 22(2):121-30. PubMed ID: 11910256
[TBL] [Abstract][Full Text] [Related]
11. Long-term safety, tolerability, and clinical efficacy of quetiapine in adolescents: an open-label extension trial.
McConville B; Carrero L; Sweitzer D; Potter L; Chaney R; Foster K; Sorter M; Friedman L; Browne K
J Child Adolesc Psychopharmacol; 2003; 13(1):75-82. PubMed ID: 12804128
[TBL] [Abstract][Full Text] [Related]
12. The effect of multiple doses of cimetidine on the steady-state pharmacokinetics of quetiapine in men with selected psychotic disorders.
Strakowski SM; Keck PE; Wong YW; Thyrum PT; Yeh C
J Clin Psychopharmacol; 2002 Apr; 22(2):201-5. PubMed ID: 11910267
[TBL] [Abstract][Full Text] [Related]
13. Tolerability of extended-release quetiapine fumarate compared with immediate-release quetiapine fumarate in older patients with Alzheimer's disease with symptoms of psychosis and/or agitation: a randomised, double-blind, parallel-group study.
De Deyn PP; Eriksson H; Svensson H;
Int J Geriatr Psychiatry; 2012 Mar; 27(3):296-304. PubMed ID: 21538537
[TBL] [Abstract][Full Text] [Related]
14. Multiple dose pharmacokinetics of quetiapine and some of its metabolites in Chinese suffering from schizophrenia.
Li KY; Li X; Cheng ZN; Peng WX; Zhang BK; Li HD
Acta Pharmacol Sin; 2004 Mar; 25(3):390-4. PubMed ID: 15000896
[TBL] [Abstract][Full Text] [Related]
15. Self-reported sedation profile of quetiapine extended-release and quetiapine immediate-release during 6-day initial dose escalation in bipolar depression: a multicenter, randomized, double-blind, phase IV study.
Riesenberg RA; Baldytcheva I; Datto C
Clin Ther; 2012 Nov; 34(11):2202-11. PubMed ID: 23059166
[TBL] [Abstract][Full Text] [Related]
16. A study of quetiapine: efficacy and tolerability in psychotic adolescents.
Shaw JA; Lewis JE; Pascal S; Sharma RK; Rodriguez RA; Guillen R; Pupo-Guillen M
J Child Adolesc Psychopharmacol; 2001; 11(4):415-24. PubMed ID: 11838824
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic profile of the extended-release formulation of quetiapine fumarate (quetiapine XR): clinical implications.
Bui K; Earley W; Nyberg S
Curr Med Res Opin; 2013 Jul; 29(7):813-25. PubMed ID: 23574265
[TBL] [Abstract][Full Text] [Related]
18. Steady-state pharmacokinetics and tolerability of orally administered fampridine sustained-release 10-mg tablets in patients with multiple sclerosis: a 2-week, open-label, follow-up study.
Vollmer T; Blight AR; Henney HR
Clin Ther; 2009 Oct; 31(10):2215-23. PubMed ID: 19922892
[TBL] [Abstract][Full Text] [Related]
19. Effect of quetiapine and norquetiapine on anxiety and depression in major psychoses using a pharmacokinetic approach: a prospective observational study.
Altamura AC; Moliterno D; Paletta S; Buoli M; Dell'osso B; Mauri MC; Bareggi SR
Clin Drug Investig; 2012 Mar; 32(3):213-9. PubMed ID: 22299714
[TBL] [Abstract][Full Text] [Related]
20. Open-label study of the effect of combination quetiapine/lithium therapy on lithium pharmacokinetics and tolerability.
Potkin SG; Thyrum PT; Bera R; Carreon D; Alva G; Kalali AH; Yeh C
Clin Ther; 2002 Nov; 24(11):1809-23. PubMed ID: 12501876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
